109 related articles for article (PubMed ID: 11434778)
1. Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands.
Hong DP; Hagihara Y; Kato H; Goto Y
Biochemistry; 2001 Jul; 40(27):8092-100. PubMed ID: 11434778
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78.
Hagihara Y; Enjyoji K; Omasa T; Katakura Y; Suga K; Igarashi M; Matsuura E; Kato H; Yoshimura T; Goto Y
J Biochem; 1997 Jan; 121(1):128-37. PubMed ID: 9058203
[TBL] [Abstract][Full Text] [Related]
3. The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroEL.
Smoot AL; Panda M; Brazil BT; Buckle AM; Fersht AR; Horowitz PM
Biochemistry; 2001 Apr; 40(14):4484-92. PubMed ID: 11284705
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship.
Matsuura E; Inagaki J; Kasahara H; Yamamoto D; Atsumi T; Kobayashi K; Kaihara K; Zhao D; Ichikawa K; Tsutsumi A; Yasuda T; Triplett DA; Koike T
Int Immunol; 2000 Aug; 12(8):1183-92. PubMed ID: 10917893
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids.
Hagihara Y; Hong DP; Hoshino M; Enjyoji K; Kato H; Goto Y
Biochemistry; 2002 Jan; 41(3):1020-6. PubMed ID: 11790126
[TBL] [Abstract][Full Text] [Related]
6. The interaction of beta(2)-glycoprotein I domain V with chaperonin GroEL: the similarity with the domain V and membrane interaction.
Gozu M; Hoshino M; Higurashi T; Kato H; Goto Y
Protein Sci; 2002 Dec; 11(12):2792-803. PubMed ID: 12441378
[TBL] [Abstract][Full Text] [Related]
7. Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance.
Hoshino M; Hagihara Y; Nishii I; Yamazaki T; Kato H; Goto Y
J Mol Biol; 2000 Dec; 304(5):927-39. PubMed ID: 11124037
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.
Schwarzenbacher R; Zeth K; Diederichs K; Gries A; Kostner GM; Laggner P; Prassl R
EMBO J; 1999 Nov; 18(22):6228-39. PubMed ID: 10562535
[TBL] [Abstract][Full Text] [Related]
9. Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form.
Ohkura N; Hagihara Y; Yoshimura T; Goto Y; Kato H
Blood; 1998 Jun; 91(11):4173-9. PubMed ID: 9596664
[TBL] [Abstract][Full Text] [Related]
10. Characterization of large peptide fragments derived from the N-terminal domain of the ribosomal protein L9: definition of the minimum folding motif and characterization of local electrostatic interactions.
Horng JC; Moroz V; Rigotti DJ; Fairman R; Raleigh DP
Biochemistry; 2002 Nov; 41(45):13360-9. PubMed ID: 12416980
[TBL] [Abstract][Full Text] [Related]
11. The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.
van Lummel M; Pennings MT; Derksen RH; Urbanus RT; Lutters BC; Kaldenhoven N; de Groot PG
J Biol Chem; 2005 Nov; 280(44):36729-36. PubMed ID: 16091370
[TBL] [Abstract][Full Text] [Related]
12. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system.
Igarashi M; Matsuura E; Igarashi Y; Nagae H; Ichikawa K; Triplett DA; Koike T
Blood; 1996 Apr; 87(8):3262-70. PubMed ID: 8605342
[TBL] [Abstract][Full Text] [Related]
13. Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies.
Kasahara H; Matsuura E; Kaihara K; Yamamoto D; Kobayashi K; Inagaki J; Ichikawa K; Tsutsumi A; Yasuda S; Atsumi T; Yasuda T; Koike T
Int Immunol; 2005 Dec; 17(12):1533-42. PubMed ID: 16221723
[TBL] [Abstract][Full Text] [Related]
14. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome.
Guerin J; Sheng Y; Reddel S; Iverson GM; Chapman MG; Krilis SA
J Biol Chem; 2002 Jan; 277(4):2644-9. PubMed ID: 11711550
[TBL] [Abstract][Full Text] [Related]
15. The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.
Hunt J; Krilis S
J Immunol; 1994 Jan; 152(2):653-9. PubMed ID: 7506730
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.
Sheng Y; Sali A; Herzog H; Lahnstein J; Krilis SA
J Immunol; 1996 Oct; 157(8):3744-51. PubMed ID: 8871678
[TBL] [Abstract][Full Text] [Related]
17. A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding.
Mehdi H; Naqvi A; Kamboh MI
Eur J Biochem; 2000 Mar; 267(6):1770-6. PubMed ID: 10712609
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I.
Zhang X; Rizo J; Südhof TC
Biochemistry; 1998 Sep; 37(36):12395-403. PubMed ID: 9730811
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and thermodynamics of 1-anilino-8-naphthalene sulfonate interactions with Urinary Trypsin Inhibitor.
Zuo Z; Fan H; Guo J; Zhou W; Li L
Protein J; 2012 Oct; 31(7):585-91. PubMed ID: 22875404
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the sources of protein-ligand affinity: 1-sulfonato-8-(1')anilinonaphthalene binding to intestinal fatty acid binding protein.
Kirk WR; Kurian E; Prendergast FG
Biophys J; 1996 Jan; 70(1):69-83. PubMed ID: 8770188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
